Cargando…
Base excess and hematocrit predict response to indomethacin in very low birth weight infants with patent ductus arteriosus
BACKGROUND: The treatment of patent ductus arteriosus (PDA) in very low birth weight (VLBW) infants remains a challenge. The ability to predict which infants will respond to indomethacin could spare some from the risks of unnecessary medications. Our objective was to determine if indicators of acid-...
Autores principales: | Mydam, Janardhan, Rastogi, Alok, Naheed, Zahra J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6704716/ https://www.ncbi.nlm.nih.gov/pubmed/31439021 http://dx.doi.org/10.1186/s13052-019-0706-y |
Ejemplares similares
-
Transcatheter Closure of Patent Ductus Arteriosus in Premature Infants With Very Low Birth Weight
por: Wang, Jieh-Neng, et al.
Publicado: (2021) -
Current Status of Therapeutic Strategies for Patent Ductus Arteriosus in Very-Low-Birth-Weight Infants in Korea
por: Lee, Jin A, et al.
Publicado: (2015) -
Plasma Amino Acid Concentrations at Birth and Patent Ductus Arteriosus in Very and Extremely Preterm Infants
por: Huizing, Maurice J., et al.
Publicado: (2021) -
A Case of a Full-Term Infant With Symptomatic Patent Ductus Arteriosus Successfully Closed With Indomethacin Treatment: Consideration of Mechanism for Ductus Arteriosus Closure
por: Tanabe, Junya, et al.
Publicado: (2019) -
Change in Blood Pressure and Pulse Pressure in Preterm Infants After Treatment of Patent Ductus Arteriosus With Indomethacin
por: Han, Ui Joung, et al.
Publicado: (2011)